Avoro Capital Advisors LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share (FOLD)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol
FOLD
Shares outstanding
305,970,149 shares
Disclosed Ownership
20,500,000 shares
Ownership
6.7%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 09:30:38 UTC
Date of event
31 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 6.7% 20,500,000 20,500,000 0 /s/ Scott Epstein Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh 6.7% 20,500,000 20,500,000 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually